1. Home
  2. LWLG vs IVVD Comparison

LWLG vs IVVD Comparison

Compare LWLG & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightwave Logic Inc.

LWLG

Lightwave Logic Inc.

HOLD

Current Price

$4.18

Market Cap

578.6M

Sector

Industrials

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$2.34

Market Cap

692.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LWLG
IVVD
Founded
1991
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
578.6M
692.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LWLG
IVVD
Price
$4.18
$2.34
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.33
AVG Volume (30 Days)
970.5K
12.4M
Earning Date
11-14-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$100,605.00
$50,039,000.00
Revenue This Year
N/A
$103.88
Revenue Next Year
N/A
$171.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
332.71
52 Week Low
$0.79
$0.35
52 Week High
$6.26
$3.07

Technical Indicators

Market Signals
Indicator
LWLG
IVVD
Relative Strength Index (RSI) 45.41 54.13
Support Level $3.89 $2.15
Resistance Level $4.43 $2.59
Average True Range (ATR) 0.29 0.17
MACD 0.01 -0.02
Stochastic Oscillator 48.21 50.50

Price Performance

Historical Comparison
LWLG
IVVD

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: